Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced that the ...
Tandem Diabetes Care, Inc. , a global insulin delivery and diabetes technology company, announced that the t:slim X2 insulin pump, featuring Control-IQ+ automated insulin delivery (AID) technology, is ...
Tandem Diabetes Care (Nasdaq:TNDM) today announced the rollout of its latest automated insulin delivery system integration.
Tandem Diabetes has announced that the t:slim X2 insulin pump, featuring Control-IQ+ automated insulin delivery (AID) technology, is now available with Abbott’s FreeStyle Libre 3 Plus ...
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch ...
Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.Pivot will be First Two-Part Tubeless Patch ...
A collaborative effort across 14 clinical centers in Canada and Australia reports that pregnant women with type 1 diabetes ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it ...
What is this about: On August 7, 2025, before the market opened, the company issued a press release entitled "Tandem Diabetes ...
Detailed price information for Tandem Diabetes Care (TNDM-Q) from The Globe and Mail including charting and trades.
Medpage Today on MSN
World's Best-Selling Med; Cost-Effectiveness of GLP-1 Drugs; TED Drug Heads to FDA
An Institute for Clinical and Economic Review report concluded that the GLP-1 drugs tirzepatide and semaglutide (Ozempic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback